Hematological cancers vary significantly in both prognosis and aggressiveness, demonstrating a need for tools that assist pathologists in making confident diagnoses and helping to inform clinical decisions. We offer over 65 cornerstone and novel hematopathology ready-to-use reagents, including key IHC antibodies and ISH probes, that aid in the detection of lymphomas, leukemias and other hematopoietic malignancies.
The dynamic range of VENTANA OptiView DAB IHC detection delivers high sensitivity and specificity so you can detect antigens across a wide range of expression levels. Our hematopathology assays are optimized for use on the fully-automated VENTANA BenchMark systems, maximizing quality and laboratory efficiency.
bcl-2 (SP66) Rabbit Monoclonal Primary Antibody
Roche Tissue Diagnostics hematopathology suite of ready-to-use immunohistochemistry (IHC) and in situ hybridization (ISH) assays feature:
CD30 (Ber-H2) Mouse Monoclonal Primary Antibody
We are excited to provide you with the reformulated CD30 (Ber-H2) Mouse Monoclonal Primary Antibody. A cornerstone tissue marker for lymphoma, CD30 delivers clinical confidence by aiding the pathologist in:
This reformulation features updated protocols for both OptiView DAB Detection and ultraView Universal DAB IHC Detection.